- ICH GCP
- EU臨床試験登録
最新の試験
EudraCT Number: 2004-005184-15 | Sponsor Protocol Number: 05_ENDO_46 | Start Date: 2005-05-24 | ||||||
Sponsor Name: Christie Hospital NHS Trust | ||||||||
Full Title: Central Hypothyroidism and Adjusted Thyroxine dose Study (CHATS): impact of increasing free thyroxine levels in patients with hypopituitarism | ||||||||
Medical condition: Central (secondary/tertiary) hypothyroidism (subclinical) | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: GB (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2005-000380-26 | Sponsor Protocol Number: CERTES02 (Ce-PoP-RAD001A2419) | Start Date: 2005-05-24 | |||||||||||
Sponsor Name: Novartis Farmacéutica S.A. | |||||||||||||
Full Title: A 12 month, multicenter, randomized, parallel, open-label study, to evaluate renal function and efficacy of Certican® (everolimus) with Simulect® (basiliximab) and cyclosporine discontinuation at 3... | |||||||||||||
Medical condition: Renal Transplant | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-000807-33 | Sponsor Protocol Number: EFC5823 | Start Date: 2005-05-24 | |||||||||||
Sponsor Name: sanofi-aventis recherche & développement | |||||||||||||
Full Title: Randomized, double-blind, two -arms placebo-controlled, parallel-group, multicenter study of rimonabant 20 mg once daily in the treatment of atherogenic dyslipidemia in abdominally obese patients. | |||||||||||||
Medical condition: Abdominally obese patients with atherogenic dyslipidemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) DK (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-001378-29 | Sponsor Protocol Number: RAE02 | Start Date: 2005-05-23 | ||||||
Sponsor Name: Bradford Teaching Hospitals NHS Foundation Trust | ||||||||
Full Title: A double blinded randomised controlled trial of injection of botulinum toxin versus normal saline into the puborectalis muscle in patients with pelvic floor dyssynergia. | ||||||||
Medical condition: Obstructed defeacation | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: GB (Completed) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004670-88 | Sponsor Protocol Number: 4975-2-007-2 | Start Date: 2005-05-23 | |||||||||||
Sponsor Name: AlgoRx Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Analgesic Efficacy, Safety and Tolerability of ALGRX 4975 in Subjects after Inguinal Hernia Repair | |||||||||||||
Medical condition: Inguinal Hernia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-000867-24 | Sponsor Protocol Number: ALFR-HC-04 | Start Date: 2005-05-23 | ||||||
Sponsor Name: Human Genome Sciences, Inc. | ||||||||
Full Title: A PHASE 2b, RANDOMIZED, MULTI-CENTER, ACTIVE-CONTROLLED, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALBUFERON (RECOMBINANT HUMAN ALBUMIN-INTERFERON ALFA FUSION PROTEIN) IN COMBINATION... | ||||||||
Medical condition: Hepatitis type C chronic | ||||||||
|
||||||||
Population Age: Adults | Gender: Male, Female | |||||||
Trial protocol: DE (Completed) CZ (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-002676-41 | Sponsor Protocol Number: 100388,103494,104105,104106 | Start Date: 2005-05-23 | ||||||||||||||||||||||||||
Sponsor Name: GlaxoSmithKline Biologicals | ||||||||||||||||||||||||||||
Full Title: Blinded, randomised, controlled, multicenter study to evaluate the clinical efficacy against varicella disease of GlaxoSmithKline Biologicals’ live attenuated varicella vaccine (Varilrix) given on ... | ||||||||||||||||||||||||||||
Medical condition: Healthy children between 12-22 months (including the day before the 23-month birthday) of age at the time of vaccination with no history of measles, mumps, rubella and varicella diseases/vaccination. | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: SE (Completed) LT (Completed) SK (Completed) CZ (Completed) IT (Completed) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-001774-27 | Sponsor Protocol Number: AISSM03 | Start Date: 2005-05-23 | |||||||||||
Sponsor Name: AISSM ONLUS | |||||||||||||
Full Title: CAMPATH-1H AS IMMUNOSUPPRESSIVE AGENT IN MDS PATIENTS MULTICENTRIC PILOT STUDY | |||||||||||||
Medical condition: In this study we want to assess the potential of CAMPATH-1H as an immunosuppressive agent in a series of selected MDS patients, because T lymphocytes are thought to play an important role in the ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004391-36 | Sponsor Protocol Number: AC-052-402 | Start Date: 2005-05-23 | ||||||
Sponsor Name: Actelion Pharmaceuticals Ltd. | ||||||||
Full Title: A multicenter, open-label, single-arm safety study to investigate the effects of chronic TRACLEER® treatment on testicular function in male patients with pulmonary arterial hypertension | ||||||||
Medical condition: Many endothelin receptor antagonists have profound effects on the histology and function of the testes in animals. These drugs have been shown to induce atrophy of the seminiferous tubules of the t... | ||||||||
|
||||||||
Population Age: Adults | Gender: Male | |||||||
Trial protocol: HU (Completed) CZ (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-002096-16 | Sponsor Protocol Number: 01/04 | Start Date: 2005-05-23 | ||||||
Sponsor Name: Universitätskinderklinik Innsbruck | ||||||||
Full Title: Effect of plasma volume expansion with hydroxy-ethyl-starch (HES) 130/0.4 or crystalloids on interstitial fluid accumulation and blood pressure in newborn infants with arterial hypotension | ||||||||
Medical condition: Arterial hypotension | ||||||||
|
||||||||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |||||||
Trial protocol: AT (Ongoing) | ||||||||
Trial results: (No results available) |